Equities
Health CareMedical Equipment and Services
  • Price (USD)245.39
  • Today's Change-0.71 / -0.29%
  • Shares traded2.94m
  • 1 Year change+24.68%
  • Beta0.8443
Data delayed at least 15 minutes, as of Nov 09 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in USDIncome statement in USDView more

Year on year Danaher Corp's revenues fell -10.33% from 26.64bn to 23.89bn. This along with an increase in selling, general and administrative costs has contributed to a reduction in net income from 7.21bn to 4.76bn, a -33.92% decrease.
Gross margin59.26%
Net profit margin16.57%
Operating margin20.24%
Return on assets4.67%
Return on equity7.59%
Return on investment5.19%
More ▼

Cash flow in USDView more

In 2023, Danaher Corp did not generate a significant amount of cash. However, the company earned 7.16bn from its operations for a Cash Flow Margin of 29.99%. In addition the company used 7.08bn on investing activities and also paid 273.00m in financing cash flows.
Cash flow per share8.35
Price/Cash flow per share28.66
Book value per share71.03
Tangible book value per share-14.85
More ▼

Balance sheet in USDView more

Danaher Corp has a Debt to Total Capital ratio of 25.46%, a lower figure than the previous year's 37.23%.
Current ratio1.37
Quick ratio1.01
Total debt/total equity0.3416
Total debt/total capital0.2546
More ▼

Growth rates in USD

Year on year, growth in dividends per share increased 10.42% while earnings per share excluding extraordinary items fell by -33.26%. The positive trend in dividend payments is noteworthy since very few companies in the Medical Equipment & Supplies industry pay a dividend. Additionally when measured on a five year annualized basis, dividend per share growth is above the industry average relative to its peers, while earnings per share growth is in-line with the industry average.
Div yield(5 year avg)0.39%
Div growth rate (5 year)11.32%
Payout ratio (TTM)19.50%
EPS growth(5 years)10.83
EPS (TTM) vs
TTM 1 year ago
-10.96
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.